Chirag Paswan says India working with global bodies on nutraceutical regulations

New Delhi: India is working with global regulatory bodies, like Codex Alimentarius Commission, to formulate regulations for the nutraceutical industry, which has huge growth potential, Food Processing Industries Minister Chirag Paswan said on Tuesday.

“Nutraceuticals are again one of the fastest-growing industries. When it comes to this particular sector, we need to have regulations in place,” Paswan told reporters on the sidelines of an Assocham event.

“We are working closely with international regulatory bodies like Codex to have formal regulations so that the industry can grow.”

The scope of this industry is massive, and since it is new, numerous reforms and policies need to be implemented, for which the government is currently in the process, he added.

Paswan, addressing the event, noted that the government is ready to address the gaps in the sector and urged stakeholders to suggest policy reforms.

He said the government is focusing on nutritional security, alongside food security.

India’s nutraceutical industry is experiencing rapid growth, fuelled by rising health awareness and preventive healthcare trends.

Nutraceuticals fall primarily under the Food Safety and Standards Authority of India (FSSAI) via the Food Safety and Standards Act, 2006. Core rules include FSS (Health Supplements, Nutraceuticals, etc.) Regulations, 2016, covering licensing, labelling, advertising claims, and contaminants.

Food business operators need FSSAI licenses for manufacturing and sales. Labelling must detail purpose, target groups, usage instructions, and precautions; no genetically modified ingredients are permitted currently.

Related Posts

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid